Clinical Trial Update: A Study for Patients With Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial for schizophrenia sponsored by Eli Lilly and Company has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED